14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session X : Cell death in cancer Poster X, 62<br />

The nucleoside analogue cidofovir suppresses lung metastasis <strong>and</strong> induces apoptosis in<br />

FGF2-overexpressing endothelial cells.<br />

S<strong>and</strong>ra Liekens*, Sofie Gijsbers*, Erik De Clercq*, Erik Verbeken§, <strong>and</strong> Sigrid Hatse*<br />

*Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven,<br />

Belgium <strong>and</strong> §Division of Histopathology, K.U.Leuven. E-mail:<br />

S<strong>and</strong>ra.liekens@rega.kuleuven.be<br />

Cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, (S)-HPMPC] is an<br />

antiviral drug that is clinically used for the treatment of cytomegalovirus retinitis in AIDS<br />

patients (1). Cidofovir also possesses potent activity against human papillomavirus-induced<br />

tumors in animal models <strong>and</strong> patients (1). We have recently shown that cidofovir inhibits the<br />

development of vascular tumors induced by basic fibroblast growth factor (FGF2)overexpressing<br />

endothelial (3F2T) cells in mice (2). Here, we demonstrate that the cytotoxic<br />

activity of cidofovir in 3F2T cells may result from the specific induction of apoptosis. Cell<br />

cycle analysis revealed that cidofovir induces accumulation of cells in the S phase <strong>and</strong>, upon<br />

prolonged treatment, a significant increase in sub-G1 cells, exhibiting a sub-diploid DNA<br />

content. Moreover, annexin V binding, an early event in apoptosis induction, was increased in<br />

cidofovir-treated 3F2T cells. Cidofovir also caused nuclear fragmentation <strong>and</strong> the activation<br />

of caspase-3-like proteases in 3F2T cells, as evidenced by the cleavage of poly(ADPribose)polymerase.<br />

In addition, cidofovir treatment resulted in a pronounced up-regulation of<br />

p53 protein. Protein kinase B/Akt is recognized as a principal mediator of survival signals that<br />

protect cells from undergoing apoptosis. Cidofovir did not suppress the phosphorylation of<br />

Akt nor its downstream regulator Bad, indicating that the Akt pathway is not affected by<br />

cidofovir treatment of 3F2T cells. However, cidofovir inhibited the expression of FGF2 <strong>and</strong><br />

FGF2 <strong>signaling</strong> through Erk42/44, as shown by Western blot analysis. In vivo, cidofovir<br />

markedly suppressed the development of experimental lung metastasis, induced by<br />

inoculation of 3F2T cells in the tail vein of SCID mice. Our results indicate that cidofovir<br />

may inhibit the growth of 3F2T cells via inhibition of FGF2 expression <strong>and</strong> <strong>signaling</strong>, <strong>and</strong> via<br />

the induction of apoptosis through the caspase-3 pathway.<br />

1. De Clercq <strong>and</strong> Holy (2005) Nat Rev Drug Discov. 4: 928-940.<br />

2. Liekens et al. (2001) Cancer Res. 61: 5057-5064.<br />

- 395 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!